Public
Peer-reviewed research
Browse published research organized by pathology AI topic.
Browse researchPeer-reviewed research by our team, published in top-tier journals and conferences
Start with public research, then request the product- and market-specific information relevant to your review.
Public
Browse published research organized by pathology AI topic.
Browse researchRequest
Ask for evidence scoped to the product, workflow, and intended use under review.
Request relevant evidenceRequest
Request status information for the relevant product, version, intended use, and market.
Request current statusAccess is matched to the sensitivity of the information and the scope of the review.
L1 · Public
Peer-reviewed research and high-level product information available on this website.
L2 · Qualified request
Scoped evidence and planning information may be shared after organization and use-case review.
L3 · NDA review
Detailed technical, security, or diligence materials may require confidentiality terms and an agreed review scope.
Use these questions to define the evidence and implementation scope before requesting detailed materials.
Confirm intended use, cohort relevance, reference standard, limitations, and required human review.
Review slide capacity, acceptance criteria, exception handling, training, and rollout planning.
Map scanners and formats, integrations, deployment, data flow, access controls, logging, and change management.
Verify the exact product, version, market status, document currency, support scope, and commercial assumptions.
Tell us what you are evaluating so our team can route the appropriate level of information.
Request a scoped summary of validation evidence relevant to a product and intended use.
Request validation briefAsk our team to confirm relevant scanners, formats, and workflow integration requirements for your environment.
Request compatibility reviewRequest planning information tailored to your deployment scope, roles, and validation process.
Request implementation guidanceAsk for product-, version-, and market-specific regulatory and security information appropriate to your review.
Request review packHigh-impact research from our team at top venues
Zhang, Z., Chen, P., McGough, M., ..., Cui, L., ..., Yang, L.
Read Nature MI Paper
Li, H., Zhu, C., Zhang, Y., Sun, Y., Shui, Z., Kuang, W., Zheng, S., Yang, L.
Read CVPR 2023 Paper
Li, J., Zhu, C., Zheng, S., Chen, P., Sun, Y., Li, H., Yang, L.
Read IEEE TMI PaperExplore peer-reviewed research organized around the core themes behind our pathology AI platform.
Large multimodal and generative pathology models that unify patch, report, and whole-slide understanding.
Li, J., Zhu, C., Zheng, S., Chen, P., Sun, Y., Li, H., Yang, L. · IEEE Trans. Medical Imaging · 2025
Sun, Y., Si, Y., Zhu, C., Gong, X., Zhang, K., Chen, P., Zhang, Y., Shui, Z., Lin, T., Yang, L. · CVPR 2025 (CCF-A) · 2025
Sun, Y., Zhang, Y., Si, Y., Zhu, C., Zhang, K., Shui, Z., Li, J., Gong, X., Lyu, X., Lin, T., Yang, L. · ICLR 2025 (Oral) · 2025
Sun, Y., Zhu, C., Zheng, S., Zhang, K., Sun, L., Shui, Z., Zhang, Y., Li, H., Yang, L. · AAAI 2024 (CCF-A, Oral) · 2024
Chen, P., Zhu, C., Zheng, S., Li, H., Yang, L. · ECCV 2024 (CCF-A) · 2024
Li, J., Zheng, S., Zhu, C., Sun, Y., Chen, P., Shui, Z., Zhang, Y., Li, H., Yang, L. · ACM MM 2024 (CCF-A, Oral) · 2024
Chen, P., Li, H., Zhu, C., Zheng, S., Shui, Z., Yang, L. · MICCAI 2024 (CCF-B, Oral) · 2024
Task-specific methods and clinical collaborations spanning detection, classification, synthesis, segmentation, and decision support.
Wu, X.-R., Lv, H., Zhao, S., Zeng, X.-H., Dai, L.-J., Xu, Y.-Z., Li, Y.-W., Qiu, Z.-Y., Huang, J.-T., Zhang, N.-N., Chen, L., He, M., Zhao, Y.-Z., Yang, L., Zhou, T., Li, J.-J., Wu, J., Jiang, Y.-Z., Yang, W.-T., Di, G.-H., Shao, Z.-M., Ma, D. · Signal Transduction and Targeted Therapy · 2026
Dong, Y.-h., Xu, Y.-t., Jiang, X.-z., Xu, L., Yu, R.-j., Wang, R., Zhang, Q.-f. · npj Breast Cancer · 2026
West China Hospital, Sichuan University · Clinical Study Protocol · 2026
Provenzano, E. · USCAP 2025 Oral Presentation · 2025
Li, M., Cai, M., Lv, H., Zhou, S., Lin, M., Shui, R., Yang, W. · USCAP 2024 · 2024
Li, M., Lv, H., Zhao, Y., Zhu, C., Li, H., Lin, M., Yang, W. · San Antonio Breast Cancer Symposium · 2023
Luo, X., Li, H., Chen, J., Zhou, Z., Zhou, L., Luo, R., ..., Cui, L., Yang, L., Yang, Q. · Allergy · 2026
Zhang, Y., Shui, Z., Li, H., Sun, Y., Zhu, C., Yang, L. · ICASSP 2025 (CCF-B) · 2025
Ma, D., Dai, L.-J., Wu, X.-R., Liu, C.-L., Zhao, S., Zhang, H., Chen, L., Xiao, Y., Li, M., Zhao, Y.-Z., ... · Cancer Cell · 2025
Zhang, Y., Li, H., Sun, Y., Zheng, S., Zhu, C., Yang, L. · ECCV 2024 (CCF-A) · 2024
Shui, Z., Zhang, Y., Yao, K., Zhu, C., Zheng, S., Li, J., Li, H., Sun, Y., Guo, R., Yang, L. · ECCV 2024 (CCF-A) · 2024
Li, H., Zhang, Y., Chen, P., Shui, Z., Zhu, C., Yang, L. · NeurIPS 2024 (CCF-A) · 2024
Shui, Z., Zheng, S., Zhu, C., Zhang, S., Yu, X., Li, H., Li, J., Chen, P., Yang, L. · AAAI 2024 (CCF-A) · 2024
Zhang, S., Zhu, C., Li, H., Cai, J., Yang, L. · Neural Networks · 2024
Huang, A., Zhao, Y., Guan, F., Zhang, H., ... · Computational and Structural Biotechnology Journal · 2024
Sun, Y., Zhu, C., Zheng, S., Zhang, Y., Li, H., Yang, L. · ICME 2024 (CCF-B) · 2024
Zhang, S., Zheng, S., Shui, Z., Yang, L. · ICASSP 2024 (CCF-B) · 2024
Zhang, S., Zheng, S., Shui, Z., Li, H., Yang, L. · BIBM 2024 (CCF-B) · 2024
Li, H., Zhu, C., Zhang, Y., Sun, Y., Shui, Z., Kuang, W., Zheng, S., Yang, L. · CVPR 2023 (CCF-A) · 2023
Li, H., Xu, Z., Zhou, M., Shi, X., Kang, Y., Bu, Q., Lv, H., Li, M., Lin, M., Cui, L., Feng, J., Yang, W., Yang, L. · MICCAI 2023 (CCF-B) · 2023
Li, J., Zheng, S., Shui, Z., Zhang, S., Yang, L., Sun, Y., Zhang, Y., Li, H., ... · IEEE Trans. Medical Imaging · 2023
Chen, P., Zhu, C., Shui, Z., Cai, J., Zheng, S., Zhang, S., Yang, L. · MICCAI 2023 (CCF-B) · 2023
Shui, Z., Zhang, S., Zhu, C., Wang, B., Chen, P., Zheng, S., Yang, L. · MICCAI 2022 (CCF-B) · 2022
Zheng, S., Li, J., Shui, Z., Zhu, C., Zhang, Y., Chen, P., Yang, L. · MICCAI 2022 (CCF-B) · 2022
Zhang, S., Zhu, C., Li, H., Cai, J., Yang, L. · ISBI 2022 · 2022
Cai, J., Zhu, C., Chen, P., Zhang, S., Li, H., Sun, Y., Yang, L. · ISBI 2022 · 2022
Zhu, C., Sun, Y., Li, H., Cui, C., Zhang, S., Cai, J., Ling, Y. · ISBI 2022 · 2022
Cai, J., Zhu, C., Cui, C., Li, H., Wu, T., Zhang, S., Yang, L. · MICCAI 2021 (CCF-B) · 2021
Pan, B., Kang, Y., Jin, Y., Yang, L., Zheng, Y., Cui, L., Sun, J., Feng, J., Li, Y., Guo, L., Liang, Z. · J. Translational Medicine · 2021
Li, Y., Chen, P., Li, Z., Su, H., Yang, L., Zhong, D. · Artificial Intelligence in Medicine · 2020
Zhang, Z., Chen, P., McGough, M., ..., Cui, L., ..., Yang, L. · Nature Machine Intelligence · 2019
Evaluation suites and robustness studies that measure pathology AI performance across patch and whole-slide settings.
Sun, Y., Wu, H., Zhu, C., Si, Y., Chen, Q., Zhang, Y., Zhang, K., Li, J., Cai, J., Wang, Y., ... · IEEE Trans. Medical Imaging · 2025
Sun, Y., Wu, H., Zhu, C., Zheng, S., Chen, Q., Zhang, K., Zhang, Y., Wan, D., Lan, X., ... · ECCV 2024 (CCF-A, Oral) · 2024
Zheng, S., Cui, X., Sun, Y., Li, J., Li, H., Zhang, Y., Chen, P., Jing, X., Ye, Z., Yang, L. · J. Imaging Informatics in Medicine · 2024
Sun, Y., Zhu, C., Zhang, Y., Li, H., Chen, P., Yang, L. · ICASSP 2023 (CCF-B) · 2023
Zhang, Y., Sun, Y., Li, H., Zheng, S., Zhu, C., Yang, L. · MICCAI 2022 (CCF-B) · 2022
We welcome partnerships with academic institutions, healthcare organizations, and industry leaders.